71.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$69.79
Aprire:
$70.125
Volume 24 ore:
12.77M
Relative Volume:
0.91
Capitalizzazione di mercato:
$105.65B
Reddito:
$20.08B
Utile/perdita netta:
$2.89B
Rapporto P/E:
36.72
EPS:
1.9391
Flusso di cassa netto:
$3.66B
1 W Prestazione:
+1.77%
1M Prestazione:
-6.67%
6M Prestazione:
-27.72%
1 anno Prestazione:
-28.01%
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
71.20 | 103.56B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
110.71 | 191.06B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
349.11 | 133.77B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.44 | 113.29B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
84.27 | 48.53B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
CIBC Bancorp USA Inc. Makes New $59 Million Investment in Boston Scientific Corporation $BSX - MarketBeat
Avity Investment Management Inc. Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Danica Pension Livsforsikringsaktieselskab Acquires New Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Financial Times
Boston Scientific (BSX): UBS Lowers Price Target to $105 | BSX S - GuruFocus
BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm – Company AnnouncementFT.com - Financial Times
Lombard Odier Asset Management USA Corp Acquires New Shares in Boston Scientific Corporation $BSX - MarketBeat
National Bank of Canada FI Grows Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Jain Global LLC Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Focus Partners Wealth - MarketBeat
Drug Eluting Balloon Market Market Poised Boom | Boston Scientific Corporation, BD, Terumo Corporation - openPR.com
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Financial Times
Jefferies reiterates Boston Scientific stock rating on growth outlook - Investing.com
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 – Company Announcement - Financial Times
Boston Sci’s Rezūm therapy superior to drugs in treating BPH - BioWorld MedTech
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - Business Wire
Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus - Yahoo Finance
Holocene Advisors LP Sells 2,706,169 Shares of Boston Scientific Corporation $BSX - MarketBeat
Alliancebernstein L.P. Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress? - Insider Monkey
BSX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-15) - Seeking Alpha
Boston Scientific Corporation $BSX Holdings Lifted by Capitolis Liquid Global Markets LLC - MarketBeat
California Public Employees Retirement System Cuts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
BNP Paribas Has $9.43 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Aquatic Capital Management LLC Buys New Shares in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific stock hits 52-week low at 68.19 USD By Investing.com - Investing.com Nigeria
Assessing Boston Scientific (BSX) Valuation After Recent Penumbra Acquisition And Share Price Weakness - Yahoo Finance
INVESTOR DEADLINE: Snowflake Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - GlobeNewswire Inc.
INVESTOR DEADLINE: Boston Scientific Corporation Investors - GlobeNewswire
Ossiam Lowers Holdings in Boston Scientific Corporation $BSX - MarketBeat
Prosight Management LP Buys Shares of 76,100 Boston Scientific Corporation $BSX - MarketBeat
iSAM Funds UK Ltd Invests $1.47 Million in Boston Scientific Corporation $BSX - MarketBeat
Main Street Research LLC Sells 374,847 Shares of Boston Scientific Corporation $BSX - MarketBeat
Integral Health Asset Management LLC Trims Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Banque Transatlantique SA - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific Corporation $BSX Shares Sold by Tocqueville Asset Management L.P. - MarketBeat
Sei Investments Co. Has $224 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Entropy Technologies LP Has $6.37 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Arrowstreet Capital Limited Partnership - MarketBeat
BSX News | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance
INVESTOR NOTICE: Boston Scientific Corporation Investors with Su - GuruFocus
Boston Scientific stock hits 52-week low at 68.19 USD - Investing.com South Africa
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - Barchart.com
BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology VolumesBOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt - Stock Titan
Boston Scientific Corp (NYSE:BSX): A GARP Stock with Strong Growth and Reasonable Valuation - ChartMill
Rep. Gilbert Ray Cisneros, Jr. Buys Boston Scientific Corporation (NYSE:BSX) Stock - MarketBeat
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):